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metabolism and its alterations during carnitine (C) therapy have not been studied. Ten VPA treated C deficient children equimolar C were given over a 14 days period. Before C treatment the fasting plasma levels of ammonia, taurine, aspartate, hydroxyproline, glutamate, proline, glycue, alanine, methionine were elevated, the levels of leucine and ornithine were depressed in VPA treated children as compared to controls (p<o.o5), their levels remained unchanged after C therapy. The elevated ammonia and glutamate with normal glutemine levels show impaired glutamate-glutamine cycle. After a standard meal the plasma levels of AA exhibited different elevation before and after C treatment. The urinary output of AA mas lower in the VPA treated group, output of 8 individual AA increased after the C treatment, showing that the C may influence the AA metabolism, yet most changes are C independent and are caused probably by the VPA per se. .
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CND is.a rare disorder characterized by severe unconjugated hyperbilirubinemia appearing in the first days of life and persisting throughout life. We tried to control the hyperbilirubinemia in an infant with CND by parenteral administration of Sn-Pp, a strong inhibitor of heme-oxygenas The dose administered was 0.5 ui\lol/kg b.w. Mild transient erythema appeared when the infant was exposed to sunlight after injection, but not during phototherapy. The serum clearance of Sn-Pp was found to be biphasic: over 90% of the Sn-Pp present in the serum 5 h after injection is eliminated within 48 h; the remaining Sn-Pp undergoes very slov~ clearance which is virtually complete after 7 days. Different treatment schedules have been tried; however, in no case was it possible to discontinue phototherapy. A suitable combination of phototherapy and Sn-Pp administration apepars to yield the most promising results. In particular, it is possible to maintain the serum bilirubin concentration below 14-15 mg/dl combining one injection of Sn-Pp every 7-10 days with 5 hrs of phototherapy per night. 
Department of Child Health
Liverpool Maternity Hospital, Liverpool. Despite r e c e n t c a l l s f o r the administration of o p i a t e s t o v e n t i l a t e d neswborn i n f a n t s , t h e r e is a paucity of d a t a t o support t h e i r use. Single dose s t u d i e s during surgery suggest t h a t commonly used drugs have a marked reduction i n clearance. This study e v a l u a k t h e use of a s h o r t a c t i n g s y n t h e t i c opiod, a l f e n t a n i l .
22 v e n t i l a t e d , paralysed preterm i n f a n t s with hyaline membrane d i s e a s e (median BW:1348g (r:690-4084g); median GA:30 weeks ( r : 2 5 -3 6~) ) were given 20 micrograms/Kg a l f e n t a n i l by slow intravenous i n j e c t i o n over two minutes. Peak serum concentration (med(r)) was 67ng/ml (13-606). clearance O.Sml/rnin/kg (0.6-9.62) and elimination h a l f l i f e 321 mins (64-1251). Transient depression of BP and h e a r t r a t e was noted. Using t h e s e d a t a i n s i x c h i l d r e n s a t i s f a c t o r y serum l e v e l s of a l f e n t a n i l were achieved using 20 micrograms/Kg over 30 mins followed by 5micrograms/Kg/hour with no c a r d i o r e s p i r a t o r y e f f e c t s . Recent animal experiments demonstrated t h a t the c o n t r a c t i l i t y of the inmature mvocardlum 1s suooorted larnelv by the rnflux of ~a l c i w n across'the sarcolemm'hnd only wKen-mgbfarfium matures r z t r a c e l l u l a r calcium uptake and release by t e sarcoplasmic reticulum plays an i n c r e a s i n l y i m o r t a n t r o l e I n the development nf nvocardial c o n t r a c t l f i t v . !he ouroose of t h i s studv was t h e r e f i r c t i -d e f i n e a t e the acut; hemodi.na&c e f f e c t s of pa2en-t e r a l calclum treatment I n c r r t i c a l l y 111 and hypocalcemlc pre- 
